<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Meza A</submitter><funding>NIGMS NIH HHS</funding><pagination>10700-10710</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9681013</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(17)</volume><pubmed_abstract>Multi-enzyme biocatalytic cascades are emerging as practical routes for the synthesis of complex bioactive molecules. However, the relative sparsity of water-stable carbon electrophiles limits the synthetic complexity of molecules made from such cascades. Here, we develop a chemoenzymatic platform that leverages styrene oxide isomerase (SOI) to covert readily accessible aryl epoxides into α-aryl aldehydes through a Meinwald rearrangement. These unstable aldehyde intermediates are then intercepted with a C-C bond forming enzyme, ObiH, that catalyzes a transaldolase reaction with l-threonine to yield synthetically challenging β-hydroxy-α-amino acids. Co-expression of both enzymes in &lt;i>E. coli&lt;/i> yields a whole cell biocatalyst capable of synthesizing a variety of stereopure non-standard amino acids (nsAA) and can be produced on &lt;i>gram&lt;/i>-scale. We used isotopically labelled substrates to probe the mechanism of SOI, which we show catalyzes a concerted isomerization featuring a stereospecific 1,2-hydride shift. The viability of &lt;i>in situ&lt;/i> generated α-aryl aldehydes was further established by intercepting them with a recently engineered decarboxylative aldolase to yield γ-hydroxy nsAAs. Together, these data establish a versatile method of producing α-aryl aldehydes in simple, whole cell conditions and show that these intermediates are useful synthons in C‒C bond forming cascades.</pubmed_abstract><journal>ACS catalysis</journal><pubmed_title>Efficient chemoenzymatic synthesis of α-aryl aldehydes as intermediates in C-C bond forming biocatalytic cascades.</pubmed_title><pmcid>PMC9681013</pmcid><funding_grant_id>DP2 GM137417</funding_grant_id><pubmed_authors>Grieger AM</pubmed_authors><pubmed_authors>Campbell ME</pubmed_authors><pubmed_authors>McGill MJ</pubmed_authors><pubmed_authors>Thein SA</pubmed_authors><pubmed_authors>Zmich A</pubmed_authors><pubmed_authors>Meza A</pubmed_authors><pubmed_authors>Willoughby PH</pubmed_authors><pubmed_authors>Buller AR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficient chemoenzymatic synthesis of α-aryl aldehydes as intermediates in C-C bond forming biocatalytic cascades.</name><description>Multi-enzyme biocatalytic cascades are emerging as practical routes for the synthesis of complex bioactive molecules. However, the relative sparsity of water-stable carbon electrophiles limits the synthetic complexity of molecules made from such cascades. Here, we develop a chemoenzymatic platform that leverages styrene oxide isomerase (SOI) to covert readily accessible aryl epoxides into α-aryl aldehydes through a Meinwald rearrangement. These unstable aldehyde intermediates are then intercepted with a C-C bond forming enzyme, ObiH, that catalyzes a transaldolase reaction with l-threonine to yield synthetically challenging β-hydroxy-α-amino acids. Co-expression of both enzymes in &lt;i>E. coli&lt;/i> yields a whole cell biocatalyst capable of synthesizing a variety of stereopure non-standard amino acids (nsAA) and can be produced on &lt;i>gram&lt;/i>-scale. We used isotopically labelled substrates to probe the mechanism of SOI, which we show catalyzes a concerted isomerization featuring a stereospecific 1,2-hydride shift. The viability of &lt;i>in situ&lt;/i> generated α-aryl aldehydes was further established by intercepting them with a recently engineered decarboxylative aldolase to yield γ-hydroxy nsAAs. Together, these data establish a versatile method of producing α-aryl aldehydes in simple, whole cell conditions and show that these intermediates are useful synthons in C‒C bond forming cascades.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-19T16:11:52.235Z</modification><creation>2025-04-19T16:11:52.235Z</creation></dates><accession>S-EPMC9681013</accession><cross_references><pubmed>36420479</pubmed><doi>10.1021/acscatal.2c02369</doi></cross_references></HashMap>